Domperidone


w36



General information:


Withdrawn ID: w36
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): A03FA03
Molecular Formula: C22H24ClN5O2
Molweight: 425.911



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1978
First death: 1982
First withdrawn: 1985
Last withdrawn: 1985
Reference: https://www.ncbi.nlm.nih.gov/pubmed/12377980



Side-effects:

Total reported cases (submitted by medical professionals) with Domperidone as primary suspect: 77


Reported final outcomes:
Hospitalization (initial or prolonged): 36
Death: 9
Life-Threatening condition: 7
Congenital anomaly: 2
Disability: 1


Reported side-effects:

Side-effect Case number
DRUG INTERACTION9
ELECTROCARDIOGRAM QT PROLONGED8
DYSPNOEA8
Off label use5
NAUSEA5
Chest pain5
FATIGUE4
CONFUSIONAL STATE4
Vomiting3
PRURITUS3
Palpitations3
GAMMA-GLUTAMYLTRANSFERASE INCREASED3
Diarrhoea3
CHEST DISCOMFORT3
ARRHYTHMIA3
WEIGHT DECREASED2
URTICARIA2
Urinary retention2
Therapy cessation2
Syncope2
Sudden cardiac death2
STEVENS-JOHNSON SYNDROME2
SOMNOLENCE2
SEPTIC SHOCK2
Respiratory disorder2
RENAL FAILURE2
PRODUCT QUALITY ISSUE2
Peripheral swelling2
PAIN IN EXTREMITY2
Neutropenia2
HYPONATRAEMIA2
FALL2
EXTRAPYRAMIDAL DISORDER2
Drug-induced liver injury2
DRUG INEFFECTIVE2
DEATH2
Condition aggravated2
COGNITIVE DISORDER2
BLOOD ALKALINE PHOSPHATASE INCREASED2
ASPARTATE AMINOTRANSFERASE INCREASED2
Anxiety2
ALANINE AMINOTRANSFERASE INCREASED2
AGITATION2
Acute myocardial infarction2
ABDOMINAL PAIN2
Withdrawal syndrome1
WEIGHT INCREASED1
VITAMIN B1 DEFICIENCY1
Visual impairment1
Ventricular tachycardia1
Ventricular fibrillation1
Ventricular arrhythmia1
Unresponsive to stimuli1
UMBILICAL ARTERY HYPOPLASIA1
Tubulointerstitial nephritis1
Toxicity to various agents1
Torticollis1
Torsade de pointes1
Tinnitus1
THROMBOCYTOPENIA1
Therapy change1
TENDON DISORDER1
TEARFULNESS1
TARDIVE DYSKINESIA1
SYRINGE ISSUE1
SWOLLEN TONGUE1
Sunburn1
Suicidal ideation1
Sluggishness1
SLEEP DISORDER1
Shock1
Sepsis1
Self injurious behaviour1
Rhabdomyolysis1
Respiratory failure1
RESPIRATORY DISTRESS1
Respiratory depth decreased1
RENAL IMPAIRMENT1
Renal disorder1
Rash pustular1
Rash maculo-papular1
Pulseless electrical activity1
Pulmonary hypertension1
PSYCHOMOTOR RETARDATION1
Product use issue1
Product use in unapproved indication1
Prescribed overdose1
Platelet count decreased1
Photosensitivity reaction1
Pelvic kidney1
Oropharyngeal pain1
OPISTHOTONUS1
Neurotoxicity1
Neuropathy peripheral1
NEURALGIA1
Myalgia1
Muscular weakness1
MULTI-ORGAN FAILURE1
Mouth ulceration1
MOOD ALTERED1
MALNUTRITION1
Malaise1
Loss of consciousness1
Liver function test abnormal1
LEUKOENCEPHALOPATHY1
Intussusception1
Intentional overdose1
Insomnia1
Impaired gastric emptying1
HYPOTONIA1
Hypotension1
Hypokinesia1
Hypokalaemia1
HYPOGLYCAEMIA1
Hypochloraemia1
Hyperuricaemia1
Hypertonia1
Hypertension1
Hypersensitivity1
HYPERKALAEMIA1
Hyperhidrosis1
HYPERAESTHESIA1
Hydronephrosis1
HEPATOCELLULAR DAMAGE1
HEPATITIS1
HEPATIC FAILURE1
HEPATIC ENCEPHALOPATHY1
HALLUCINATION, VISUAL1
Haemorrhage1
GRAND MAL CONVULSION1
Gingival hypertrophy1
GAZE PALSY1
Foetal exposure during pregnancy1
Flushing1
FLATULENCE1
Fixed drug eruption1
Feeling abnormal1
FACE OEDEMA1
Exposure during pregnancy1
ERYTHEMA OF EYELID1
Epilepsy1
EOSINOPHILIA1
DYSTONIA1
DYSKINESIA1
Dysarthria1
DRUG TOXICITY1
Drug reaction with eosinophilia and systemic symptoms1
Drug eruption1
DRUG EFFECT DECREASED1
Drug dependence1
DIVERTICULITIS1
DISORIENTATION1
Disease progression1
DISCOMFORT1
Diabetic ketoacidosis1
Dehydration1
Coronary artery disease1
Conjunctival haemorrhage1
Coma1
Cerebral ischaemia1
CARDIAC FAILURE1
Cardiac disorder1
Cardiac discomfort1
Cardiac arrest1
BREAST DISCOMFORT1
BREAST DISCHARGE1
Brain death1
Atrioventricular block1
ASTHENIA1
Arteriosclerosis coronary artery1
Angioedema1
Anaemia1
AMNESTIC DISORDER1
Altered state of consciousness1
Adverse event1
Acne1
ABDOMINAL PAIN UPPER1
ABDOMINAL DISTENSION1
ABDOMINAL DISCOMFORT1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
O15244 7900 Solute carrier family 22 member 2 S22A2_HUMAN
O75604 10000 Ubiquitin carboxyl-terminal hydrolase 2 UBP2_HUMAN
P02545 0.8 Prelamin-A/C LMNA_HUMAN
P14416 1.3 D(2) dopamine receptor DRD2_HUMAN
P19793 8800 Retinoic acid receptor RXR-alpha RXRA_HUMAN
P19838 141.3 Nuclear factor NF-kappa-B p105 subunit NFKB1_HUMAN
P35462 3.5 D(3) dopamine receptor DRD3_HUMAN
Q12809 57.54 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN
Q16665 2511.9 Hypoxia-inducible factor 1-alpha HIF1A_HUMAN
Q96FL8 2300 Multidrug and toxin extrusion protein 1 S47A1_HUMAN



Toxicity information:

Toxicity class: 4
Toxicity type: cardiovascular
LD50: 1000 mg/kg



External links:

ChEBML: CHEMBL219916
DrugBank: DB01184